Awadalla P., Gauthier, J., Myers R.A., Casals F., Hamdan F.F., Griffing A.R., Cote M., Henrion E., Spiegelman D., Tarabeux J., Piton A., Yang Y., Boyko A., Bustamante C., Xiong L., Rapoport J.L., Addington A.M., DeLisi J.L., Krebs M.O., Joober R., Millet B., Fombonne E., Mottron L., Zilversmit M., Keebler J., Daoud H., Marineau C., Roy-Gagnon M.H., Dube M.P., Eyre-Walker A., Drapeau P., Stone E.A., Lafreniere R.G., Rouleau G.A. (2010). Direct measure of the de novo mutation rate in autism and schizophrenia cohorts, Am J Hum Genet, 87(3), 316-324.

Bechard-Evans L., Iyer S., Lepage M., Joober R., Malla A. (2010). Investigating cognitive deficits and symptomatology across pre-morbid adjustment patterns in first-episode psychosis, Psychol Med, 40(5), 749-759.

Bodnar M., Malla A., Czechowska Y., Benoit A., Fathalli F., Joober R., Pruessner M., Pruessner J., Lepage M. (2010). Neural markers of remission in first-episode schizophrenia: a volumetric neuroimaging study of the hippocampus and amygdala, Schizophr Res, 122(1-3), 72-80.

Buchy L., Bodnar M., Malla A., Joober R., Lepage M. (2010). A 12-month outcome study of insight and symptom change in first episode psychosis, Early Interv Psychiatry, 4(1), 79-88.

Buchy L., Czechowska Y., Chochol C., Malla A., Joober R., Pruessner J., Lepage M. (2010). Toward a model of cognitive insight in first-episode psychosis: verbal memory and hippocampal structure, Schizophr Bull, 36(5), 1040-1049.

Cassidy C.M., Rabinovitch M., Schmitz N., Joober R., Malla A. (2010). A comparison study of multiple measures of adherence to antipsychotic medication in first-episode psychosis, J Clin Psychopharmacol, 30(1), 64-67.

Gauthier S., Champagne N., Lafreniere R. G., Xiong L., Spiegelman D., Brustein E., Lapointe M., Peng H., Cote M., Noreau A., Hamdan F. F., Addington A. M., Rapoport J. L., Delisi L. E., Krebs M. O., Joober R., Fathalli F., Mouaffak F., Haghighi A. P., Neri C., Dube M. P., Samuels M. E., Marineau C., Stone E. A., Awadalla P., Barker P. A., Carbonetto S., Drapeau P., Rouleau G. A. (2010). De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia, Proc Natl Acad Sci U S A, 107(17), 7863-8.

Grizenko N., Paci M., Joober R. (2010). Is the inattentive subtype of ADHD different from the combined/hyperactive subtype?, J Atten Disord, 13(6), 649-57.

Joober R., Boksa P. (2010). Clozapine: a distinct, poorly understood and under-used molecule, J Psychiatry Neurosci, 35(3), 147-9.

Krebs M. O., Joober R. (2010). [The genetics of schizophrenia: back to the clinic?], Encephale, 36(2), 91-3.

Lepage M., Bodnar M., Buchy L., Joober R., Malla A. (2010). Early Medication Adherence and Insight Change in First-Episode Psychosis, Clin Schizophr Relat Psychoses, 3(4), 201-208.

Lepage M., Bodnar M., Joober R., Malla A. (2010). Is there an association between neurocognitive performance and medication adherence in first episode psychosis?, Early Interv Psychiatry, 4(2), 189-95.

Luck D., Malla A., Joober R., Lepage M. (2010). Disrupted integrity of the fornix in first-episode schizophrenia, Schizophr Res, 119(1-3), 61-64.

Malla A., Lal S., Vracotas N.C., Goldberg K., Joober R. (2010). Early intervention in psychosis: specialized intervention and early case identification, Encephale, 36 Suppl 3, S38-45. Find out more.

Montreuil T., Bodnar M., Bertrand M.C., Malla A., Joober R., Lepage M. (2010). Social cognitive markers of short-term clinical outcome in first-episode psychosis, Clin Schizophr Relat Psychoses, 4(2), 105-114.

Tabareux J., Champagne N., Brustein E., Hamdan F.F., Gauthier J., Lapointe M., Maios C., Piton A., Spiegelman D., Henrion E., Millet B., Rapoport J.L., Delisi L.E., Joober R., Fathalli F., Fombonne E., Mottron L., Forget-Dubois N., Boivin M., Michaud J.L., Lafreniere R.G., Drapeau P., Krebs M.O., Rouleau G.A. (2010). De novo truncating mutation in Kinesin 17 associated with schizophrenia, Biol Psychiatry, 68(7), 649-656.

Taylor V.A., Ellenbogen M.A., Washburn D., Joober R. (2010). The effects of glucocorticoids on the inhibition of emotional information: a dose-response study, Biol Psychol.

Ter-Stepanian M., Grizenko N., Zappitelli M., Joober R. (2010). Clinical response to methylphenidate in children diagnosed with attention-deficit hyperactivity disorder and comorbid psychiatric disorders, Can J Psychiatry, 55(5), 305-312.

Thakur G.A., Grizenko N., Sengupta S.M., Schmitz N., Joober R. (2010). The 5-HTTLPR polymorphism of the serotonin transporter gene and short term behavioral response to methylphenidate in children with ADHD, BMC Psychiatry, 10, 50.